Modeling the regulation of p53 activation by HIF-1 upon hypoxia
- PMID: 31282018
- DOI: 10.1002/1873-3468.13525
Modeling the regulation of p53 activation by HIF-1 upon hypoxia
Abstract
As a famous tumor suppressor, p53 is also activated under hypoxic conditions. Hypoxia-inducuble factor 1, HIF-1, is involved in the activation of p53 upon hypoxia. However, how p53 is modulated by the HIF-1 pathway to decide cell fate is less understood. In this work, we developed a network model including p53 and HIF-1 pathways to clarify the mechanism of cell fate decision in response to hypoxia. We found that HIF-1α and p53 are activated under different conditions. Under moderate hypoxia, HIF-1α is activated to induce glycolysis or angiogenesis, and promotes partial accumulation of p53 by inducing PNUTS. Under severe hypoxia, p53 rises to high levels due to ATR-dependent stabilization and promotes Mdm2-dependent HIF-1α degradation. As a result, fully activated p53 triggers apoptosis. Of note, competition for p300 between HIF-1α and p53 plays a key role in regulating their transcriptional activities. This work may advance the understanding of the mechanism for p53 regulation by HIF-1 in the hypoxic response.
Keywords: HIF-1α; cell fate decision; hypoxia; network model; p53 activation.
© 2019 Federation of European Biochemical Societies.
Similar articles
-
Modeling the interplay between the HIF-1 and p53 pathways in hypoxia.Sci Rep. 2015 Sep 8;5:13834. doi: 10.1038/srep13834. Sci Rep. 2015. PMID: 26346319 Free PMC article.
-
CSB modulates the competition between HIF-1 and p53 upon hypoxia.Math Biosci Eng. 2019 Jun 10;16(5):5247-5262. doi: 10.3934/mbe.2019262. Math Biosci Eng. 2019. PMID: 31499711
-
BP-1T, an antiangiogenic benzophenone-thiazole pharmacophore, counteracts HIF-1 signalling through p53/MDM2-mediated HIF-1α proteasomal degradation.Angiogenesis. 2017 Feb;20(1):55-71. doi: 10.1007/s10456-016-9528-3. Epub 2016 Oct 14. Angiogenesis. 2017. PMID: 27743086
-
HIF-1alpha and p53 as targets of NO in affecting cell proliferation, death and adaptation.Curr Mol Med. 2004 Nov;4(7):741-51. doi: 10.2174/1566524043359926. Curr Mol Med. 2004. PMID: 15579021 Review.
-
HIPK2-a therapeutical target to be (re)activated for tumor suppression: role in p53 activation and HIF-1α inhibition.Cell Cycle. 2010 Apr 1;9(7):1270-5. doi: 10.4161/cc.9.7.11125. Cell Cycle. 2010. PMID: 20234185 Review.
Cited by
-
A system-level model reveals that transcriptional stochasticity is required for hematopoietic stem cell differentiation.NPJ Syst Biol Appl. 2024 Dec 5;10(1):145. doi: 10.1038/s41540-024-00469-8. NPJ Syst Biol Appl. 2024. PMID: 39639033 Free PMC article.
-
Aggressive variant prostate cancer: A case report and literature review.World J Clin Cases. 2023 Sep 16;11(26):6213-6222. doi: 10.12998/wjcc.v11.i26.6213. World J Clin Cases. 2023. PMID: 37731555 Free PMC article.
-
Systems biology of angiogenesis signaling: Computational models and omics.WIREs Mech Dis. 2022 Jul;14(4):e1550. doi: 10.1002/wsbm.1550. Epub 2021 Dec 30. WIREs Mech Dis. 2022. PMID: 34970866 Free PMC article. Review.
-
Exploring the synergistic pharmacological mechanism of Huoxiang Drink against irritable bowel syndrome by integrated data mining and network pharmacology.Medicine (Baltimore). 2023 Sep 29;102(39):e35220. doi: 10.1097/MD.0000000000035220. Medicine (Baltimore). 2023. PMID: 37773835 Free PMC article.
-
MDM2 Inhibition in the Treatment of Glioblastoma: From Concept to Clinical Investigation.Biomedicines. 2023 Jul 2;11(7):1879. doi: 10.3390/biomedicines11071879. Biomedicines. 2023. PMID: 37509518 Free PMC article. Review.
References
-
- Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3, 721-732.
-
- Ivan M, Kondo K, Yang H, Kim W, Valiando J, Ohh M, Salic A, Asara JM, Lane WS and Kaelin WG Jr (2001) HIF-1α targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292, 464-468.
-
- Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML and Bruick RK (2002) FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev 16, 1466-1471.
-
- Bieging KT, Mello SS and Attardi LD (2014) Unravelling mechanisms of p53-mediated tumour suppression. Nat Rev Cancer 14, 359-370.
-
- Roos WP, Thomas AD and Kaina B (2016) DNA damage and the balance between survival and death in cancer biology. Nat Rev Cancer 16, 20-33.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous